학술논문
Results of a Nonrandomized, Open-Label, Phase II Study of Combined Gemcitabine, Mitoxantrone, and Rituximab in Relapsed or Refractory Mantle Cell Lymphoma.
Document Type
Abstract
Author
Source
In Blood 16 November 2007 110(11):4452-4452
Subject
Language
ISSN
0006-4971